BRPI0412207A -
triazolotriazine compounds and uses thereof
- Google Patents
triazolotriazine compounds and uses thereof
Info
Publication number
BRPI0412207A
BRPI0412207ABRPI0412207-0ABRPI0412207ABRPI0412207ABR PI0412207 ABRPI0412207 ABR PI0412207ABR PI0412207 ABRPI0412207 ABR PI0412207ABR PI0412207 ABRPI0412207 ABR PI0412207A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/874,743external-prioritypatent/US7122548B2/en
Application filed by Sugen IncfiledCriticalSugen Inc
Publication of BRPI0412207ApublicationCriticalpatent/BRPI0412207A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
"COMPOSTOS TRIAZOLOTRIAZINA E UTILIZAçõES DOS MESMOS". A presente invenção refere-se a compostos de fórmula (I) e a sais farmaceuticamente aceitáveis dos mesmos. Estes compostos modulam a atividade de c-Met e por isso espera-se que sejam úteis na prevenção e no tratamento de distúrbios relacionados com c-Met tal como câncer."Triazolotriazine compounds and uses thereof". The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds modulate c-Met activity and are therefore expected to be useful in preventing and treating c-Met related disorders such as cancer.
BRPI0412207-0A2003-07-022004-06-25
triazolotriazine compounds and uses thereof
BRPI0412207A
(en)
Compounds, process for the manufacture of such compounds, pharmaceutical compositions comprising them, process for the treatment and / or prophylaxis of diseases and use of the compounds
compounds, process for their manufacture, pharmaceutical compositions comprising them, method for the treatment and / or prevention of diseases that are associated with the modulation of h3 receptors and their use